Colossal Biosciences Considering New Funding Round with Valuation of Up to $30 Billion
AI startup Colossal Biosciences is in discussions for a new funding round that could value the de-extinction company at up to $30 billion, according to Axios. The valuation reflects growing investor interest despite skepticism from some scientists.
Topics: AI startup biotech de-extinction